407 related articles for article (PubMed ID: 7425449)
21. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
Cunningham J; Mauch P; Rosenthal DS; Canellos GP
Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
[TBL] [Abstract][Full Text] [Related]
22. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
23. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
[TBL] [Abstract][Full Text] [Related]
24. Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
Berkowicz M; Rath P; Aghai E; Many A; Ben-Bassat I; Hulu N; Ramot B; Brenner H
Isr J Med Sci; 1978 Dec; 14(12):1275-82. PubMed ID: 748241
[TBL] [Abstract][Full Text] [Related]
25. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
Babini L; Sciascia R; Baccarani M; Emiliani E; Fiacchini M; Franchini A; Lauria F; Tura S
Radiol Med; 1978 Feb; 64(2):113-8. PubMed ID: 684251
[No Abstract] [Full Text] [Related]
26. [The current state of curability of Hodgkin's disease].
Streuli RA; Ultmann JE
Schweiz Med Wochenschr; 1981 Sep; 111(36):1301-3. PubMed ID: 7302531
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Zhou L; Wang Q; Feng F
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):333-5. PubMed ID: 11778565
[TBL] [Abstract][Full Text] [Related]
28. EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's disease.
Pogliani EM; Deliliers GL; Baldini L; Tosi A; Butti C; Chiorboli O; Confalonieri C; Fava S; Giorgetti MC; Maioli M; Maiolo AT; Marinoni P; Montalbetti L; Mozzana R; Pavia G; Pinotti G; Rossini F; Vanoli P; Venco A; Cassi E
Haematologica; 1996; 81(1):8-14. PubMed ID: 8900846
[TBL] [Abstract][Full Text] [Related]
29. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
Diehl LF; Perry DJ; Terebelo H; Baldwin PE; Hurwitz M; Kimball DB; Dorn RV
Cancer Treat Rep; 1983 Sep; 67(9):827-9. PubMed ID: 6883360
[TBL] [Abstract][Full Text] [Related]
30. The therapy of Hodgkin's disease in Nigeria: a five year study.
Oluboyede OA; Esan GJ
Afr J Med Med Sci; 1976 Sep; 5(3):201-7. PubMed ID: 829730
[TBL] [Abstract][Full Text] [Related]
31. [Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy].
Marinone G; Maiolini E; Buttolo Q; Mauro PL; Colle R
Minerva Med; 1975 Apr; 66(31):1466-71. PubMed ID: 48218
[TBL] [Abstract][Full Text] [Related]
32. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
33. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Pivnik AV; Rastrigin NA; Moiseeva TN; Lutsenko IN; Dudarova RG; Shavlokhov VS; Efimov IV; Kozhurin SV; Shitareva IV; Gemdzhian EG; Tsyba NN; Kolosova LIu; Melikian AL; Skidan NI; Pan'shin GA; Sotnikov VM; Dotsenko PV; Nechistiuk AV
Ter Arkh; 2006; 78(8):57-62. PubMed ID: 17078219
[TBL] [Abstract][Full Text] [Related]
34. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Tsushita K; Utsumi M; Shimoyama M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
[TBL] [Abstract][Full Text] [Related]
35. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
[TBL] [Abstract][Full Text] [Related]
36. [Results of therapy in Hodgkin's disease with special reference to polychemotherapy (MOPP)].
Büchi G; Cervellera M; Vigna-Taglianti G; Denna V; Navone R
Minerva Med; 1976 Dec; 67(59):3913-20. PubMed ID: 826854
[TBL] [Abstract][Full Text] [Related]
37. Management of Hodgkin's disease.
Desforges JF; Rutherford CJ
Compr Ther; 1979 Feb; 5(2):63-9. PubMed ID: 428209
[No Abstract] [Full Text] [Related]
38. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
39. Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.
Jenkin D; Chan H; Freedman M; Greenberg M; Gribbin M; McClure P; Saunders F; Sonley M
Cancer Treat Rep; 1982 Apr; 66(4):949-59. PubMed ID: 7042093
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
